Logo

pneumonia

OpGen, Fisher Healthcare Ink Distribution Deal for Unyvero MDx System

The nonexclusive distribution partnership is expected to increase US commercial adoption of the highly multiplexed PCR system.

Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium

Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.

Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform

BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.

Sequencing Study Highlights Vaccine-Dodging Streptococcus Pneumoniae Lineage

Researchers turned to whole-genome sequences to characterize S. pneumoniae serotypes that became prominent after the introduction of a pneumococcal conjugate vaccine.

OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
Premium

The company expects the trial results to bolster sales by increasing physician confidence in the panel.

Mar 1, 2021

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

May 19, 2020

BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases
Premium

Apr 21, 2020

Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients

Dec 20, 2019

FDA Clears Curetis Lower Respiratory Tract Infections Panel

Jun 10, 2019

Streptococcus Pneumoniae Changes in Response to Vaccine Introduction, Global Genomic Survey Finds

Apr 11, 2019

Curetis 2018 Revenues Grow 17 Percent

Feb 6, 2019

AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests

Feb 4, 2019

Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval

Jan 30, 2019

Curetis Receives Malaysia, Thailand Regulatory Approvals

Dec 13, 2018

Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

Nov 13, 2018

BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

Oct 11, 2018

Curetis Extends Distribution Agreement With Beijing Clear Biotech in China

May 17, 2018

Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test

Apr 19, 2018

BioMérieux Q1 Revenues Up 3 Percent

Apr 4, 2018

Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance

Feb 6, 2018

Curetis Gets Singapore Approval for Pneumonia Test

Jul 31, 2017

IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests

May 12, 2017

Metagenomic Analysis Tool Taxonomer IDs Multiple Pathogens From Clinical Samples

May 11, 2017

With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship
Premium

Oct 26, 2016

Curetis Wraps Up US Clinical Trial for Lower Respiratory Infection Panel; Readies FDA Submission
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.